Wilms Joris

CIK 00017532311 companyNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001753231

Recent Transactions

26 trades

Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−35,700→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−20,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−32,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−20,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−20,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−35,700→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−20,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−20,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Common Stock
2025-09-16−39,301→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−20,000→ 0 total
Disposition from Tender
Y-mAbs Therapeutics, Inc.
Common Stock
2025-09-16$8.60/sh−12,799→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−32,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−42,900→ 0 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-01-17+42,900→ 42,900 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2025-01-17+21,500→ 52,100 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2024-08-26$14.69/sh−5,000→ 30,600 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2024-01-18+17,800→ 35,600 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-01-18+35,700→ 35,700 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-01-26+32,000→ 32,000 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-01-17+35,700→ 35,700 total
Award
Y-mAbs Therapeutics, Inc.
Common stock
2023-01-17+17,800→ 17,800 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2022-04-26+20,000→ 20,000 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2021-12-14+32,000→ 32,000 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2020-12-15+20,000→ 20,000 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2019-12-10+20,000→ 20,000 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2018-12-11−20,000→ 20,000 total

Companies

Y-mAbs Therapeutics, Inc.
SVP & CHIEF OPERATING OFFICER

Recent Filings

Address

C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE, SUITE 3350

NEW YORK, NY, 10169

View on SEC.gov